Clinical and histopathological features of myeloid neoplasms with concurrent Janus kinase 2 (<i>JAK2</i>) V617F and KIT proto‐oncogene, receptor tyrosine kinase (<i>KIT</i>) D816V mutationsNicole Naumann, Juliana Schwaab, Mohamad Jawhar et al.|British Journal of Haematology|2021Cited by 17